BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Clinical ink - ECPv6.11.2.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:Clinical ink X-ORIGINAL-URL:https://www.clinicalink.com X-WR-CALDESC:Events for Clinical ink REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:UTC BEGIN:STANDARD TZOFFSETFROM:+0000 TZOFFSETTO:+0000 TZNAME:UTC DTSTART:20220101T000000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Asia/Krasnoyarsk BEGIN:STANDARD TZOFFSETFROM:+0700 TZOFFSETTO:+0700 TZNAME:+07 DTSTART:20230101T000000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20250429 DTEND;VALUE=DATE:20250501 DTSTAMP:20250501T135912 CREATED:20250307T142240Z LAST-MODIFIED:20250307T142347Z UID:20268-1745884800-1746057599@www.clinicalink.com SUMMARY:15th Annual Outsourcing in Clinical Trials Europe 2025 (OCT Europe) DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/oct-europe-2025/ LOCATION:Hyatt Regency Barcelona Tower\, Barcelona\, Spain CATEGORIES:Industry Events ATTACH;FMTTYPE=image/webp:https://www.clinicalink.com/wp-content/uploads/2025/03/15th-Annual-Outsourcing-in-Clinical-Trials-Europe-2025.webp END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20250401 DTEND;VALUE=DATE:20250403 DTSTAMP:20250501T135912 CREATED:20250307T141050Z LAST-MODIFIED:20250307T142418Z UID:20259-1743465600-1743638399@www.clinicalink.com SUMMARY:2nd Annual Clinical Outsourcing Group Nordics (COG Nordics) DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/cog-nordics-2025/ LOCATION:Scandic Triangeln\, Malmö\, Sweden CATEGORIES:Industry Events ATTACH;FMTTYPE=image/png:https://www.clinicalink.com/wp-content/uploads/2025/03/COG-Nordics-2025.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20250326 DTEND;VALUE=DATE:20250327 DTSTAMP:20250501T135912 CREATED:20250225T221308Z LAST-MODIFIED:20250314T155842Z UID:20190-1742947200-1743033599@www.clinicalink.com SUMMARY:Webinar - Innovation Labs: Accelerating Innovation at the Intersection of Pharmaceutical Research and Digital Health DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/accelerating-innovation-at-the-intersection-of-pharmaceutical-research-webinar/ CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://www.clinicalink.com/wp-content/uploads/2025/02/Mar-26-2025-25q065-Clinical-ink-22-V5.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20250318 DTEND;VALUE=DATE:20250321 DTSTAMP:20250501T135912 CREATED:20250228T145646Z LAST-MODIFIED:20250307T135802Z UID:20226-1742256000-1742515199@www.clinicalink.com SUMMARY:DIA Europe 2025 DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/dia-europe-2025/ LOCATION:Congress Center Basel CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2025/02/dia-europe-2025.jpeg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20250312 DTEND;VALUE=DATE:20250314 DTSTAMP:20250501T135912 CREATED:20250228T130421Z LAST-MODIFIED:20250307T141646Z UID:20212-1741737600-1741910399@www.clinicalink.com SUMMARY:Operational Excellence in Clinical Trials Summit (OECT Summit) 2025 DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/oect-summit-2025/ LOCATION:Eurostars Berlin Hotel CATEGORIES:Industry Events ATTACH;FMTTYPE=image/webp:https://www.clinicalink.com/wp-content/uploads/2025/02/Operational-Excellence-in-Clinical-Trials-Summit-OECT-Summit-image-scaled.webp END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20250225 DTEND;VALUE=DATE:20250227 DTSTAMP:20250501T135912 CREATED:20250225T224727Z LAST-MODIFIED:20250225T224727Z UID:20202-1740441600-1740614399@www.clinicalink.com SUMMARY:Decentralized & Hybrid Clinical Trials 2025 Europe DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/decentralized-trials-congress-2025/ LOCATION:Copthorne Tara Hotel Kensington\, London\, UK CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2025/02/DCT-25.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20250211 DTEND;VALUE=DATE:20250213 DTSTAMP:20250501T135912 CREATED:20250225T224349Z LAST-MODIFIED:20250225T224349Z UID:20197-1739232000-1739404799@www.clinicalink.com SUMMARY:17th Annual Outsourcing in Clinical Trials West Coast 2025 DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/oct-west-2025/ LOCATION:Hyatt Regency San Francisco Airport\, Burlingame\, CA\, USA CATEGORIES:Industry Events ATTACH;FMTTYPE=image/webp:https://www.clinicalink.com/wp-content/uploads/2025/02/annual-outsourcing-clinical-trials-west-coast-2025-thumbnail.webp END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20250203 DTEND;VALUE=DATE:20250207 DTSTAMP:20250501T135912 CREATED:20250123T150334Z LAST-MODIFIED:20250123T205647Z UID:20024-1738540800-1738886399@www.clinicalink.com SUMMARY:SCOPE Summit 2025 DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/scope-summit-2025/ LOCATION:Rosen Shingle Creek\, 9939 Universal Blvd\, Orlando\, FL\, United States CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2025/01/SCOPE_clinical_ink_2025-e1737572287612.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20250130 DTEND;VALUE=DATE:20250131 DTSTAMP:20250501T135912 CREATED:20250123T205532Z LAST-MODIFIED:20250224T152914Z UID:20043-1738195200-1738281599@www.clinicalink.com SUMMARY:Webinar - Electronic Data Capture Redefined: Challenging the Norm with eSource Innovation DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/electroni-data-capture-redefined-webinar/ CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://www.clinicalink.com/wp-content/uploads/2025/01/Jan-30-2025-25q028-Clinical-Ink-21-V4-e1737663428605.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20240312 DTEND;VALUE=DATE:20240315 DTSTAMP:20250501T135912 CREATED:20240304T182111Z LAST-MODIFIED:20250123T210703Z UID:19263-1710201600-1710460799@www.clinicalink.com SUMMARY:A feasibility study of smartphone sensors to assess the effect of acute high altitude (3\,800m) exposure on cognition and motor function in healthy participants. DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/a-feasibility-study-of-smartphone-sensors-to-assess-the-effect-of-acute-high-altitude-3800m-exposure-on-cognition-and-motor-function-in-healthy-participants/ END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20240213 DTEND;VALUE=DATE:20240214 DTSTAMP:20250501T135912 CREATED:20240207T205301Z LAST-MODIFIED:20240207T210356Z UID:19245-1707782400-1707868799@www.clinicalink.com SUMMARY:GlucoseReady™: A Digital Platform for Assessing Behavior\, Glucose\, Symptoms\, and Biometrics in Cardiometabolic Disease. DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/glucoseready-a-digital-platform-for-assessing-behavior-glucose-symptoms-and-biometrics-in-cardiometabolic-disease/ ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2024/02/scope_banner_300x250.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20231205 DTEND;VALUE=DATE:20231206 DTSTAMP:20250501T135912 CREATED:20231128T224417Z LAST-MODIFIED:20250328T143856Z UID:19040-1701734400-1701820799@www.clinicalink.com SUMMARY:New Approaches to Adherence and Prevention of Dropouts: The Digital Era of Patient Engagement DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/new-approaches-to-adherence-and-prevention-of-dropouts-the-digital-era-of-patient-engagement/ CATEGORIES:Webinar END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20230830 DTEND;VALUE=DATE:20230831 DTSTAMP:20250501T135912 CREATED:20230905T132939Z LAST-MODIFIED:20230905T133112Z UID:18441-1693353600-1693439999@www.clinicalink.com SUMMARY:Predicting ALS Progression in Remote Sensor-Based Assessments DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/predicting-als-progression-in-remote-sensor-based-assessments/ CATEGORIES:Industry Events ATTACH;FMTTYPE=image/png:https://www.clinicalink.com/wp-content/uploads/2023/09/ipmds_noscrn.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20230713 DTEND;VALUE=DATE:20230714 DTSTAMP:20250501T135912 CREATED:20230627T144358Z LAST-MODIFIED:20241021T161924Z UID:17856-1689206400-1689292799@www.clinicalink.com SUMMARY:How Patient-Centered Technologies Can Elevate Diabetes Clinical Trials to Align with Current Standards of Care DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/how-patient-centered-technologies-can-elevate-diabetes-clinical-trials-to-align-with-current-standards-of-care/ CATEGORIES:Webinar END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20230607 DTEND;VALUE=DATE:20230608 DTSTAMP:20250501T135912 CREATED:20230510T151546Z LAST-MODIFIED:20241021T162034Z UID:17587-1686096000-1686182399@www.clinicalink.com SUMMARY:Solving Data Collection Challenges in Lupus Trials with the Electronic Lupus Assessment Suite DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/solving-data-collection-challenges-in-lupus-trials-with-the-electronic-lupus-assessment-suite/ CATEGORIES:Webinar END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20230419 DTEND;VALUE=DATE:20230420 DTSTAMP:20250501T135912 CREATED:20230307T221854Z LAST-MODIFIED:20250123T210607Z UID:16672-1681862400-1681948799@www.clinicalink.com SUMMARY:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/the-future-of-data-platforms-for-digital-biomarkers-accelerating-parkinsons-disease-and-movement-disorders-research/ CATEGORIES:Webinar END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20230312 DTEND;VALUE=DATE:20230313 DTSTAMP:20250501T135912 CREATED:20230307T220512Z LAST-MODIFIED:20231013T210511Z UID:16644-1678579200-1678665599@www.clinicalink.com SUMMARY:SXSW LIVE PODCAST PANEL - Innovative Data Approaches to Clinical Trial Recruitment DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/sxsw-live-podcast-panel-innovative-data-approaches-to-clinical-trial-recruitment/ CATEGORIES:Other ATTACH;FMTTYPE=image/png:https://www.clinicalink.com/wp-content/uploads/2023/03/SxSW_logo.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20230301 DTEND;VALUE=DATE:20230303 DTSTAMP:20250501T135912 CREATED:20230111T215526Z LAST-MODIFIED:20231013T203510Z UID:13082-1677628800-1677801599@www.clinicalink.com SUMMARY:Outsourcing In Clinical Trials West Coast 2023 DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/outsourcing-in-clinical-trials-west-coast-2023/ LOCATION:Hyatt Regency San Francisco Airport\, 1333 Old Bayshore Hwy\, Burlingame\, CA\, United States CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/OCT.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20230206 DTEND;VALUE=DATE:20230210 DTSTAMP:20250501T135912 CREATED:20230111T215439Z LAST-MODIFIED:20231013T203428Z UID:13075-1675641600-1675987199@www.clinicalink.com SUMMARY:SCOPE Summit 2023 (Orlando\, Florida + Virtual) DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/scope-summit-2023/ LOCATION:Rosen Shingle Creek\, 9939 Universal Blvd\, Orlando\, FL\, United States CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2023/01/scope_2023_logo.jpeg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20221130 DTEND;VALUE=DATE:20221202 DTSTAMP:20250501T135912 CREATED:20221130T000000Z LAST-MODIFIED:20230307T202509Z UID:11703-1669766400-1669939199@www.clinicalink.com SUMMARY:Outsourcing in Clinical Trials DACH 2022 DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/outsourcing-clinical-trials-dach-2022/ LOCATION:Holiday In\, Munich\, City Centre\, Munich\, Germany CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/OCT.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20221117 DTEND;VALUE=DATE:20221121 DTSTAMP:20250501T135912 CREATED:20221117T000000Z LAST-MODIFIED:20231013T203541Z UID:11700-1668643200-1668988799@www.clinicalink.com SUMMARY:CNS Summit DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/cns-summit/ LOCATION:The Boca Raton\, 501 East Camino Real\, Boca Raton\, FL\, United States CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/11/CNS-SUMMIT-LOGO_Primary_vertical.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20221114 DTEND;VALUE=DATE:20221116 DTSTAMP:20250501T135912 CREATED:20221114T080000Z LAST-MODIFIED:20220930T084845Z UID:11697-1668384000-1668556799@www.clinicalink.com SUMMARY:European Site Solutions Summit: Partnering for Success DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/esss-2022/ LOCATION:Hotel Cascais Miragem\, Av.Marginal n.8554\, Lisbon\, Portugal CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/EU_SSS_Logo_1200x600.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20221107 DTEND;VALUE=DATE:20221110 DTSTAMP:20250501T135912 CREATED:20221107T080000Z LAST-MODIFIED:20220930T084857Z UID:11694-1667779200-1668038399@www.clinicalink.com SUMMARY:Clinical Trials Europe DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/clinical-trials-europe-2022/ LOCATION:RAI Amsterdam\, Europaplein\, Amsterdam\, Netherlands CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/Clinical-Trials-Europe_jpeg-1200x600-1.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20221106 DTEND;VALUE=DATE:20221110 DTSTAMP:20250501T135912 CREATED:20221106T000000Z LAST-MODIFIED:20230327T223133Z UID:11688-1667692800-1668038399@www.clinicalink.com SUMMARY:DTRA - Decentralized Trials & Research Alliance 2022 Annual Meeting DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/dtra-annual-meeting-2022/ LOCATION:Encore Boston Harbour\, 1 Broadway\, Everett\, MA\, 02149\, United States CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/DTRA-LOGO-blue-01_2_jpeg-1200x600-1.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20221025 DTEND;VALUE=DATE:20221027 DTSTAMP:20250501T135912 CREATED:20221025T080000Z LAST-MODIFIED:20231013T203610Z UID:10744-1666656000-1666828799@www.clinicalink.com SUMMARY:OCT Outsourcing Clinical Trials Nordics DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/oct-nordics-2022/ LOCATION:Scandic\, Copenhagen\, Vester Søgade 6\, Copenhagen\, Denmark CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/OCT.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20221012 DTEND;VALUE=DATE:20221014 DTSTAMP:20250501T135913 CREATED:20221012T000000Z LAST-MODIFIED:20231013T203618Z UID:10741-1665532800-1665705599@www.clinicalink.com SUMMARY:OCT Outsourcing Clinical Trials New England DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/oct-new-england-2022/ LOCATION:The Westin\, Copely Place\, Boston\, MA\, United States CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/OCT.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20221007 DTEND;VALUE=DATE:20221010 DTSTAMP:20250501T135913 CREATED:20221007T080000Z LAST-MODIFIED:20220930T084935Z UID:11458-1665100800-1665359999@www.clinicalink.com SUMMARY:SCRS Global Site Solutions Summit (Hollywood\, Florida) DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/scrs-global-site-solutions-summit/ LOCATION:Diplomat Beach Resort\, 3555 S Ocean Dr.\, Hollywood\, FL\, United States CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/SCRS_Logo_1200x600.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20220928 DTEND;VALUE=DATE:20220930 DTSTAMP:20250501T135913 CREATED:20220928T080000Z LAST-MODIFIED:20231013T203627Z UID:10730-1664323200-1664495999@www.clinicalink.com SUMMARY:OCT Outsourcing Clinical Trials Southern California DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/oct-southern-california-2022/ LOCATION:San Diego Marriott La Jolla\, 4240 La Jolla Village Drive\, La Jolla\, CA\, United States CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/OCT.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20220921 DTEND;VALUE=DATE:20220923 DTSTAMP:20250501T135913 CREATED:20220921T080000Z LAST-MODIFIED:20220930T084956Z UID:10734-1663718400-1663891199@www.clinicalink.com SUMMARY:Global Clinical Trials Connect 2022 DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/global-clinical-trials-connect-2022/ LOCATION:Virtual Event CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/SCDM.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20220915 DTEND;VALUE=DATE:20220919 DTSTAMP:20250501T135913 CREATED:20220915T080000Z LAST-MODIFIED:20231013T210910Z UID:10725-1663200000-1663545599@www.clinicalink.com SUMMARY:International Congress of Parkinson’s Disease and Movement Disorders DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/parkinsons-disease-movement-disorders-congress-2022/ LOCATION:Marriott Auditorium Hotel and Coference Centre\, Avda de Aragón\, Madrid\, Spain CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/IPMDS.jpg END:VEVENT END:VCALENDAR